NeuroPace Inc — Director's Dealing 2021

Apr 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2021-04-21

Reporting Person: Garfield Greg Shaw (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-21	Common Stock	P	13235	$17.00	Acquired	38853	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-21	Stock Option (Right to Buy)	$17.00	A	21698	Acquired	2031-04-20	Common Stock (21698)	Direct

Footnotes

F1: Reflects shares purchased from the underwriters in the Companys initial public offering.

F2: 1/36th of the shares subject to the option vest in equal monthly installments commencing May 21, 2021.